Bio-Rad Laboratories Announces Q3 2024 Financial Results
Bio-Rad Laboratories, Inc. (NYSE: BIO), a prominent player in life science research and clinical diagnostics, is set to report its financial performance for the third quarter of 2024. The announcement will occur after the market closes on a Wednesday, hinting at crucial insights for investors and stakeholders alike.
Details of the Reporting Schedule
Following the release of the financial results, the management team at Bio-Rad is scheduled to conduct a conference call to discuss these findings. This call is set to happen at 2 PM Pacific Time, which translates to 5 PM Eastern Time. Investors and analysts are encouraged to participate, as the context provided by management will shed light on performance metrics and strategic initiatives moving forward.
How to Join the Conference Call
Individuals wishing to take part in this informative session can do so by dialing 800-579-2543 within the United States or 785-424-1789 for international access. The access code for the conference is BIORAD. This is an excellent opportunity for market participants to gain insights directly from the management.
Accessing Live and Recorded Content
A live webcast will be included in the conference call, allowing those unable to join via phone to listen in. This webcast can be found in the 'Investor Relations' section of the company’s website, specifically under 'Events & Presentations'. Furthermore, for those who cannot attend in real-time, a recording of the webcast will be available for up to a year, ensuring continued access to the valuable content shared.
Understanding Bio-Rad’s Business Model
Bio-Rad Laboratories, Inc. has firmly established itself as a leader in the development, manufacturing, and marketing of a diverse range of products in both life science research and clinical diagnostics markets. With its headquarters in Hercules, California, the company's operations span a global network that includes research, development, manufacturing, and sales functions. In recent reports, Bio-Rad has been noted to employ approximately 7,700 individuals and generates roughly $2.7 billion in revenue annually.
Who Are Bio-Rad's Customers?
Bio-Rad’s clientele includes an extensive array of institutions such as universities, research facilities, hospitals, as well as laboratories focused on food safety and environmental quality. Additionally, biopharmaceutical companies rely on Bio-Rad's innovative solutions to support their research and operational needs.
Innovation and Impact of Bio-Rad’s Products
The commitment of Bio-Rad to enhancing the quality and efficacy of its products significantly contributes to advancing scientific research and improving life quality. Their offerings have often been recognized for their high-quality standards, ensuring reliability in various critical applications.
Learn More About Bio-Rad
For those interested in understanding more about the company and its offerings, further information can be found through their dedicated website, which provides insights into their product portfolio and latest updates.
Frequently Asked Questions
What is the date for Bio-Rad’s Q3 2024 financial results?
Bio-Rad is scheduled to report its Q3 2024 financial results on a Wednesday, following the market close.
How can I participate in the conference call?
You can join the conference call by dialing 800-579-2543 within the U.S. or 785-424-1789 from abroad, using access code BIORAD.
Will there be a webcast of the conference call?
Yes, a live webcast will be available, and it can be accessed from the Investor Relations section of Bio-Rad's website.
How long will the webcast replay be available?
The recorded version of the webcast will be accessible for up to one year after the event.
What is Bio-Rad’s primary focus?
Bio-Rad focuses on developing products for life science research and clinical diagnostics, which are crucial in advancing scientific research and healthcare.
